1. Christodoulou, Eirini, van Doorn, Remco, Visser, Mijke, Jochemsen, Aart, Gruis, Nelleke. 2019. NEK11 as a candidate high-penetrance melanoma susceptibility gene. In Journal of medical genetics, 57, 203-210. doi:10.1136/jmedgenet-2019-106134. https://pubmed.ncbi.nlm.nih.gov/31704778/
2. Guo, Lei, Wang, Zhen-Bo, Wang, Hong-Hui, Hou, Yi, Sun, Qing-Yuan. 2016. Nek11 regulates asymmetric cell division during mouse oocyte meiotic maturation. In Biochemical and biophysical research communications, 474, 667-672. doi:10.1016/j.bbrc.2016.05.002. https://pubmed.ncbi.nlm.nih.gov/27150633/
3. Liu, Xia, Gao, Yutao, Lu, Yi, Li, Li, Yin, Fuqiang. 2014. Downregulation of NEK11 is associated with drug resistance in ovarian cancer. In International journal of oncology, 45, 1266-74. doi:10.3892/ijo.2014.2503. https://pubmed.ncbi.nlm.nih.gov/24969318/
4. Noguchi, Kohji, Fukazawa, Hidesuke, Murakami, Yuko, Uehara, Yoshimasa. 2002. Nek11, a new member of the NIMA family of kinases, involved in DNA replication and genotoxic stress responses. In The Journal of biological chemistry, 277, 39655-65. doi:. https://pubmed.ncbi.nlm.nih.gov/12154088/
5. Fry, Andrew M, O'Regan, Laura, Sabir, Sarah R, Bayliss, Richard. 2012. Cell cycle regulation by the NEK family of protein kinases. In Journal of cell science, 125, 4423-33. doi:10.1242/jcs.111195. https://pubmed.ncbi.nlm.nih.gov/23132929/
6. Gao, Wen-Liang, Niu, Lei, Chen, Wei-Ling, Zhang, Yong-Qu, Huang, Wen-He. 2022. Integrative Analysis of the Expression Levels and Prognostic Values for NEK Family Members in Breast Cancer. In Frontiers in genetics, 13, 798170. doi:10.3389/fgene.2022.798170. https://pubmed.ncbi.nlm.nih.gov/35368696/
智鼠故事 
